These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9004066)

  • 1. Fluoxetine and suicidal ideation.
    Ratan DA
    J Clin Psychopharmacol; 1997 Feb; 17(1):61-2. PubMed ID: 9004066
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants and side effects.
    Grounds D; Stocky A; Evans P; Scott C; McIntosh R; Morrison E; Derham H; Yeatman R; Farnbach P
    Aust N Z J Psychiatry; 1995 Mar; 29(1):156-7. PubMed ID: 7625967
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia.
    Hansen L
    J Psychopharmacol; 2003 Dec; 17(4):451-2. PubMed ID: 14870959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small numbers, big impact.
    Smoller JW; Nierenberg AA
    Harv Rev Psychiatry; 1999; 7(2):109-13. PubMed ID: 10471249
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy.
    Power AC; Cowen PJ
    Br J Psychiatry; 1992 Dec; 161():735-41. PubMed ID: 1306668
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible combination of clozapine and specific serotonin reuptake inhibitors?].
    Caroli F; Aymard N; Viala A; Smagghe PO
    Encephale; 1995; 21(6):482-3. PubMed ID: 8674476
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluoxetine, akathisia and suicide].
    Lançon C; Bernard D; Bougerol T
    Encephale; 1997; 23(3):218-23. PubMed ID: 9333553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide risk and efficacy of antidepressant drugs.
    Carroll BJ
    JAMA Psychiatry; 2013 Jan; 70(1):123-4. PubMed ID: 23303338
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe and moderate hypertriglyceridemia secondary to citalopram and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2000; 41(5):448-9. PubMed ID: 11015636
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia associated with fluoxetine.
    Dubovsky SL; Thomas M
    Psychiatr Serv; 1996 Sep; 47(9):991-3. PubMed ID: 8875667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide risk and efficacy of antidepressant drugs--reply.
    Gibbons RD; Brown CH; Hur K; Davis JM; Mann JJ
    JAMA Psychiatry; 2013 Jan; 70(1):123-5. PubMed ID: 23303376
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia.
    Purdon SE; Snaterse M
    Can J Psychiatry; 1998 Feb; 43(1):84-5. PubMed ID: 9494753
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse events reported by anxious school refusing adolescents receiving cognitive behavioral therapy with and without fluoxetine.
    Melvin GA; Finnin L; Taffe J; Dudley AL; Klimkeit EI; Gordon MS; Tonge B
    Clin Child Psychol Psychiatry; 2019 Oct; 24(4):892-905. PubMed ID: 30638065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate data and measures lead to questionable conclusions.
    Spielmans GI; Jureidini J; Healy D; Purssey R
    JAMA Psychiatry; 2013 Jan; 70(1):121-2. PubMed ID: 23303283
    [No Abstract]   [Full Text] [Related]  

  • 18. Inappropriate data and measures lead to questionable conclusions--reply.
    Gibbons RD; Brown CH; Hur K; Davis JM; Mann JJ
    JAMA Psychiatry; 2013 Jan; 70(1):122-3. PubMed ID: 23303298
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
    Giner L; Nichols CM; Zalsman G; Oquendo MA
    Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine-induced suicidality, serotonin, and seasonality.
    Brewerton TD
    Biol Psychiatry; 1991 Jul; 30(2):190-6. PubMed ID: 1912109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.